AzTrials
AzTrials

Delayed Gastric EmptyingNCT02635399

Impact of Additional DJ (Duodenojejunostomy)-Pexy on Reduction in Delayed Gastric Emptying Following Pylorus-preserving Pancreaticoduodenectomy: A Prospective, Randomized Controlled Trial

A study testing PPPD (pylorus-preserving pancreaticoduodenectomy) and PPPD (pylorus-preserving pancreaticoduodenectomy) with DJ-pexy in people with Delayed Gastric Emptying, run by Yonsei University at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Surgical resection in periampullary cancer using pancreaticoduodenectomy is the most important modality in the treatment. In the past, pancreaticoduodenectomy was associated with high morbidity and mortality. Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Delayed Gastric Emptying
What is being tested?
PPPD (pylorus-preserving pancreaticoduodenectomy) and PPPD (pylorus-preserving pancreaticoduodenectomy) with DJ-pexy
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
78 participants
Where
1 siteSouth Korea
Study dates
1 Jan 2016to Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All periampullary pathologic conditions that require PPPD
  • Age ≥20 and ≤80
  • General performance status: the Karnofsky score> 70% or ECOG 0-1

Who cannot join

  • Unresectable or locally advanced, metastatic case
  • patients who do not want surgery
  • ASA (American society of anesthesiologists' physical status classification) score: ≥3
  • patients with drug or alcohol addiction
  • patients showing low compliance
  • patients who not want to involve the clinical trial
Show all 11Show fewer
  • patients who are unable to read or understand the informed consent, sign a consent form (eg, mental retardation, blindness, illiteracy, foreign, etc.)
  • pylorus can not be preserved
  • Patients undergoing laparoscopic PPPD
  • Additional resection of adjacent organs or vascular resection was performed
  • Previous history of open surgery

Trial locations and contacts

1 site in 1 country.

South Korea1 site, 1 recruiting
  • Severance Hospital

    Seoul, 120-752

    Chang Moo Kang, MD, 82-2-2228-2100, cmkang@yuhs.ac

    Recruiting

Other trials in South Korea

About this study

Surgical resection in periampullary cancer using pancreaticoduodenectomy is the most important modality in the treatment. In the past, pancreaticoduodenectomy was associated with high morbidity and mortality. However, with the advances in techniques, including perioperative patient management, development of antibiotics, diagnostic radiology, and interventional treatments, pancreaticoduodenectomy is now considered a safe and feasible operation. Postoperative complication rates are reported to be in 10 to 20% in experienced hospitals and operation related mortality is at about 1%. Therefore, surgical treatment for periampullary cancer is actively considered.

However, postoperative complications, such as postoperative pancreatic fistula, (POPF) delayed gastric emptying, intraabdominal abscess, and postoperative bleeding, are still serious complications. Among these complications, delayed gastric emptying is considered less critical. However, delayed gastric emptying (DGE) can cause poor oral intake, which in turn, may lead to delay in recovery of postoperative nutritional state and in severe cases, requires insertion of levine tube and long-term fasting.

Read more

There have been many hypotheses for cause of DGE after pancreaticoduodenectomy, but definite cause have not been discovered yet. With the introduction of pylorus-preserving pancreaticoduodenectomy (PPPD), incidences of DGE were initially reported to have increased. However, results of most randomized comparative studies had concluded that PPPD and PD have no significance in occurence of DGE.

One hypothesis for cause of DGE we present here has to do with anatomic positioning of anastomosis site, especially pancreatojejunostomy (PJ) and duodenojejunostomy (DJ), after PPPD. Reconstruction after PPPD positions PJ and DJ close to each other. PJ site is often associated with one of postoperative complications, POPF. POPF may create inflammation around PJ site and pancreatitis, which may lead to severe adhesion around PJ as a secondary change. This adhesion and inflammation may cause DJ, which is located near PJ, to be pulled towards PJ site. When DJ is pulled towards PJ site, distal DJ site can become angulated and gastric contents may not beadle to pass easily. Gastric contents may be stagnated in stomach and thereby causing DGE. Therefore, in this study, we will fixate DJ on transverse colon using sutures, and prevent possibility of angulation of DJ. This additional procedure may reduce occurence of DGE.

Being tested
PPPD (pylorus-preserving pancreaticoduodenectomy), PPPD (pylorus-preserving pancreaticoduodenectomy) with DJ-pexy
Keywords
pancreaticoduodenectomy, delayed gastric emptying, duodenojejunopexy
Medical subject headings
Gastroparesis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PPPD (pylorus-preserving pancreaticoduodenectomy)Procedure or surgery

    pylorus-preserving pancreaticoduodenectomy is done in a conventional method. Additional DJ-pexy is performed for experimental group. DJ-pexy is performed by anchoring DJ site to transverse colon so that DJ is fixed to its original position.

  • PPPD (pylorus-preserving pancreaticoduodenectomy) with DJ-pexyProcedure or surgery

    pylorus-preserving pancreaticoduodenectomy is done in a conventional method. Additional DJ-pexy is performed for experimental group. DJ-pexy is performed by anchoring DJ site to transverse colon so that DJ is fixed to its original position.

Study groups in NCT02635399
Study groupRoleWhat they receive
conventional groupPlacebo comparatorConventional PPPD
Receives: Procedure: PPPD (pylorus-preserving pancreaticoduodenectomy)
DJ-pexy groupExperimentalPPPD with additional DJ-pexy to anchor DJ to transverse colon
Receives: Procedure: PPPD (pylorus-preserving pancreaticoduodenectomy) with DJ-pexy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Occurence of clinically relevant DGE

    DGE is defined by International Study Group of Pancreatic Surgery consensus definition. Clinically relevant grade B or C will be recorded and occurrence rate of DGE between the arms will be compared.

    Measured: With the first 30days after surgery

Secondary outcomes (1)
  1. Risk factors influencing DGE

    Preoperative, intraoperative, and postoperative variables will analyzed statistically between the arms

    Measured: Within the first 30 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Dec 2015 (estimated)
  2. Study start1 Jan 2016
  3. Primary completionDec 2019 (estimated)
  4. Study completionDec 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02635399
Sponsor's protocol ID
4-2015-0969
Status last verified
Mar 2019
First submitted
15 Dec 2015
Last updated
26 Mar 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Khan AS, Hawkins WG, Linehan DC, Strasberg SM. A technique of gastrojejunostomy to reduce delayed gastric emptying after pancreatoduodenectomy. J Gastrointest Surg. 2011 Aug;15(8):1468-71. doi: 10.1007/s11605-011-1471-4. Epub 2011 Feb 24.

    PubMed 21347870

Questions about this trial

What is this clinical trial studying?

A study testing PPPD (pylorus-preserving pancreaticoduodenectomy) and PPPD (pylorus-preserving pancreaticoduodenectomy) with DJ-pexy in people with Delayed Gastric Emptying, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Occurence of clinically relevant DGE (time frame: With the first 30days after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02635399, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Mar 2019; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in